Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 February 2018 Photo Earl Coetzee
Faculty of Health Sciences welcomes new Vice-Dean Prof Joyce Tsoka-Gwegweni
Prof Joyce Tsoka-Gwegweni, Vice-Dean for Research, Transformation, and Marketing in the Faculty of Health Sciences.

The Faculty of Health Sciences at the University of the Free State is proud to introduce the new Vice-Dean for Research, Transformation, and Marketing – Prof Joyce Tsoka-Gwegweni. This seasoned academic has 24 years of health science research experience and holds a PhD (University of KwaZulu-Natal), two master’s degrees (MSc from the University of Natal; MPH from the University of the Western Cape), two honours degrees (BSc Hons from the University of Reading; BA Hons from the University of South Africa) and management diplomas and certificates from reputable local and international institutions (University for Durham, University of Stellenbosch, UKZN, Unisa). She has also published more than 50 papers and held various high-profile leadership positions.

Prof Tsoka-Gwegweni joined the UFS on 1 February 2018.

“I think I am at the right place,
at the right time, for the right
reasons. I do not regret choosing
the UFS.”

A born academic
“I went for a scholarship interview with the British Council in 1987, and they asked me what job I’d like after studying,” Prof Tsoka-Gwegweni remembers. “I told the interview panel that I planned to work at the university!” She studied for A-levels, a junior degree and postgraduate qualifications in the UK, and further postgraduate studies in South Africa.

No place like home

Having experienced various locations around the world, South Africa remains her favourite. “I won’t trade the beautiful weather and nature, or the friendly atmosphere and people for anything from abroad,” she says. “But had I not gone to the UK, I would not have learnt to appreciate South Africa as my country.”

Big plans for Health Science research
Prof Tsoka-Gwegweni hopes for an adequate health workforce for South Africa, which is competent, committed and caring. In the Faculty of Health Sciences, she hopes to drive research by providing research leadership. “I would like to encourage the staff to enjoy research and not see it as a burden. My ambition is to improve our research profile towards a top research faculty.”

At peace in the City of Roses
Off campus, Prof Tsoka-Gwegweni enjoys going to church, listening to gospel music and going to concerts, reading, travelling, and nature. “I’m looking forward to having a great and rewarding time in Bloemfontein. But more importantly, to make a positive impact,” she says, “no matter how small. I think I am at the right place, at the right time, for the right reasons. I do not regret choosing the UFS.”

 

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept